Literature DB >> 13753894

Clinical evaluation of thioguanosine.

I H KRAKOFF, R R ELLISON, C T TAN.   

Abstract

Entities:  

Keywords:  LEUKEMIA/therapy; MERCAPTOPURINE/therapy; NEOPLASMS/therapy

Mesh：

Substances：

Year:  1961        PMID： 13753894

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  2 in total

1.  6-Thioguanine: high-dose 2-H infusions in goats.

Authors:  T J Schouten; R A De Abreu; E D Schretlen; M B van Leeuwen; J M van Baal; G A de Vaan
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

2.  Phase II trial of 6-thioguanine administered as 120 hour continuous infusion for refractory or recurrent small cell lung cancer. A Southwest Oncology Group study.

Authors:  S K Williamson; J Crowley; R B Livingston; G Weiss
Journal:  Invest New Drugs       Date:  1993-02       Impact factor: 3.850
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.